The ISPE Membership Committee hosted another successful “New Member and Early-Stage Career Luncheon” during the 40th ISPE Annual meeting in Berlin.
There are approximately 7,000 rare diseases which collectively impact more than 250 million people globally (US FDA, 2019 )(Wakap et al., 2020 ).
Get caught up on the web: did you know that you can access ISPE’s recorded meeting materials and webinars online at the ISPE Education Center?
Two months have passed since ISPE Annual 2024. Over the course of six days, participants engaged in courses, presented their latest research and were able to join in the festivities of celebrating the 40th edition of ICPE. We hope you had a wonderful time at the conference!
Dear friends and colleagues,
Welcome to the fifth MiPaL Newsletter!
This newsletter is meant to facilitate communication within the MiPaL SIG and the larger community of perinatal pharmacoepidemiologists. Please feel free to circulate this newsletter to anyone interested in pregnancy & lactation.
I am delighted to introduce the inaugural edition of our new newsletter, ISPE Insights.
We look forward to welcoming you to the ISPE 2024 Annual Meeting in Berlin!
With the growing consideration and acceptance of real-world evidence (RWE) by regulatory agencies and health technology assessment bodies in decision-making, the use of real-world data sources (RWDS) has become an ever-increasing interest of the ISPE community.
The DDI SIG hosts quarterly journal clubs, offering a platform for sharing and discussing the latest DDI research.
Celebrating 40 years of ISPE
We hope you’ve enjoyed the career talks and technical webinars presented so far this year.
The Medications in Pregnancy and Lactation (MiPaL) SIG invites you to view our May 2024 newsletter.
